Classification
- Anatomical main groupDDermatologicals
- Therapeutic subgroupD07
- Pharmacological subgroupD07A
- Chemical subgroupD07AC
- Chemical substanceD07AC21Ulobetasol
Where it is registered
Each register with its number of medicines and a few of them.
Loading your page…
Each register with its number of medicines and a few of them.
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
Anvisa · 1 medicine
Every register, a page at a time. Strengths and packs are on each medicine’s page.
16 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Halobetasol Propionate | United States | 0.05% | ointment | Marketed | Cosette |
| Halobetasol Propionate | United States | 0.05% | cream | Marketed | Sun Pharma Canada |
| Halobetasol Propionate | United States | 0.05% | aerosol, foam | Marketed | Padagis Israel |
| Ultravate | United States | 0.05% | lotion | Marketed | Lacer Pharma |
| Halobetasol Propionate and TazaroteneCombination | United States | 0.01%; 0.045% | lotion | Marketed | Sun Pharma Canada |
| Halobetasol Propionate | United States | 0.05% | lotion | Not marketed | Padagis Israel |
| Bryhali | United States | 0.01% | lotion | Marketed | Bausch |
| DuobriiCombination | United States | 0.01%; 0.045% | lotion | Marketed | Bausch |
| Ultravate | Canada | 0.05 % / W/W | Ointment | Marketed | Bausch Health, Canada INC. |
| Ultravate | Canada | 0.05 % / W/W | Cream | Marketed | Bausch Health, Canada INC. |
| Halobex | Brazil | Authorised | Glenmark Farmacêutica Ltda | ||
| Ultravate | United States | 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ointment | Not marketed | Sun Pharm Inds INC |
| Ultravate | United States | 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | cream | Not marketed | Sun Pharm Inds INC |
| Bryhali | Canada | 0.01 % / W/W | Lotion | Marketed | Bausch Health, Canada INC. |
| DuobriiCombination | Canada | 0.01 % / W/W + 0.045 % / W/W | Lotion | Marketed | Bausch Health, Canada INC. |
| Lexette | United States | 0.05% | aerosol, foam | Not marketed | Mayne Pharma |
The same brand on several registers.
The companies holding its medicines, the most first.
Substances it shares a medicine with.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of Anvisa, FDA and Health Canada. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.